| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.83 | 0.005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.75 | 0.007 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |